This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Since I was a child, I always wanted to be a doctor. From a human point of view, I have always considered doctors’ work as a sort of mission for the good of others. Being a doctor means giving courage and hope day in, day out to those experiencing illness.
I felt that I belonged there and decided to pursue a career in the pharma industry. My peers in most of the organisations I worked at earlier in my career were not doctorates. After working for pharmacompanies for nearly 20 years, I decided to work with USP so that I could utilise my skills in the development of standards.
Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceuticalcompanies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.
Eryn has a wealth of expertise in diverse therapeutic areas and, after her experiences with battling cancer, a commitment to advancing the pharmaceutical industry by merging conventional and alternative treatments into one model. Get to know Eryn with this Q&A: What motivated you to pursue a doctorate degree? Then fate intervened.
Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceuticalcompanies to stay ahead of the game. Compliance ensures that interactions between pharmaceuticalcompanies and KOLs are transparent, fair, and free from any undue influence.
This week, another pharmacompany revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose.
His current research concerns the use of quantum chemistry and machine learning to understand chemical reactivity, with the aim of providing insights into the most widely used reaction classes in pharmaceutical synthesis and enabling chemists to design and optimise new synthetic routes to molecules. big pharma or startups/spin off?
3 Another considerable obstacle to pharmaceuticalcompanies’ interest (and investment) is the fact that for a product to be patentable — and therefore profitable — it has to be considered new and inventive. 4 But the same barriers still exist today. UTIs, diabetic foot ulcers).
WITHOUT doctors, physical therapists or chiropractors. Our Unique Solution Has Been Featured All Over The Media, From Hallmark, The Doctors, Atlanta Live & Arizona Midday…. Before I show you what this breakthrough pain solution is, I want to let you in on the “dirty little secret” of the pharmaceutical industry.
Ensuring access to safe and effective treatments is the main challenge faced by pharmaceuticalcompanies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine?
Well, the simple fact is your doctor, pharmacist, and even most health professionals haven’t heard of it either…. I’m not a doctor and I don’t have any fancy letters after my name. See, I believe that most doctors are hard working and well-meaning professionals. Who I am and why you should even care what I have to say….
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content